Where could SIBN trade next? Consensus target price: $23.
Get informed when a big investor buys or sells
+ Follow$18.5
3 analysts in the last 4 months
High: $25 | Low: $21
No recommendations in the last 4 months.
As of the most recent data, SIBN shows a target price of $23. Scroll down for historical charts and peer comparison views.
If SI-BONE moved to the average analyst target of $23, shares would be roughly 26.1% higher than $18.5. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of SI-BONE's earnings trajectory.
Besides this target price page, Stockcircle has SI-BONE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $23) with ownership activity and broader fundamentals.
SI-BONE's target price is $23; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.